{"acute febrile neutrophilic dermatosis": 75.52, "acute myeloid leukaemia": 18.96, "acute respiratory distress syndrome": 8.98, "acute respiratory failure": 5.04, "agranulocytosis": 4.47, "anaemia": 2.45, "aortitis": 146.32, "bacterial infection": 6.35, "bone marrow failure": 7.78, "bone pain": 15.69, "capillary leak syndrome": 37.57, "clostridium difficile infection": 6.38, "cytopenia": 6.12, "disease progression": 3.51, "drug exposure before pregcy": 82.88, "drug ineffective for unapproved indication": 5.72, "febrile neutropenia": 28.36, "graft versus host disease": 13.26, "haemophagocytic lymphohistiocytosis": 8.62, "hepatotoxicity": 2.91, "hypoxia": 3.23, "ill-defined disorder": 3.38, "immune reconstitution inflammatory syndrome": 44.32, "infection": 4.98, "leukocytosis": 10.01, "leukopenia": 3.63, "mucosal inflammation": 11.82, "multiple organ dysfunction syndrome": 5.63, "myelodysplastic syndrome": 12.67, "neoplasm progression": 2.43, "neuropathy peripheral": 2.11, "neutropenia": 9.3, "neutrophil count decreased": 2.76, "neutrophil count increased": 21.68, "neutrophilia": 26.38, "off label use": 4.24, "pancytopenia": 3.82, "platelet count decreased": 2.05, "pleural effusion": 2.47, "pneumonitis": 4.45, "product use in unapproved indication": 3.2, "respiratory failure": 2.92, "sepsis": 3.76, "septic shock": 3.91, "skin lesion": 3.24, "splenic rupture": 47.86, "staphylococcal bacteraemia": 23.07, "staphylococcal infection": 3.63, "therapeutic product effect incomplete": 2.03, "therapy non-responder": 6.67, "therapy partial responder": 12.53, "thrombocytopenia": 4.17, "treatment failure": 3.99, "white blood cell count decreased": 3.44, "white blood cell count increased": 8.66}